Chest
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gosker, H. R.
Right arrow Articles by Schols, A. M. W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gosker, H. R.
Right arrow Articles by Schols, A. M. W. J.
(Chest. 2003;123:1416-1424.)
© 2003 American College of Chest Physicians

Striking Similarities in Systemic Factors Contributing to Decreased Exercise Capacity in Patients With Severe Chronic Heart Failure or COPD*

Harry R. Gosker, MSc; Nicole H. M. K. Lencer, MD; Frits M. E. Franssen, MD; Ger J. van der Vusse, PhD; Emiel F. M. Wouters, PhD, FCCP and Annemie M. W. J. Schols, PhD

* From the Departments of Pulmonology (Mr. Gosker, and Drs. Franssen, Wouters, and Schols), Cardiology (Dr. Lencer), and Physiology (Dr. van der Vusse), University of Maastricht, Maastricht, the Netherlands.

Correspondence to: Harry R. Gosker, MSc, Maastricht University, PO Box 616, 6200 MD Maastricht, the Netherlands; e-mail: H.Gosker{at}pul.unimaas.nl

Aims: Chronic heart failure (CHF) and COPD are both characterized by muscular impairment. To assess whether the severity and functional consequences of muscular impairment are disease specific, we compared skeletal muscle function, body composition, and daily activity level relative to exercise capacity between these two disorders.

Methods: Twenty-five patients with CHF and 25 patients with COPD, and 36 healthy gender- and age-matched control subjects underwent measurement of fat-free mass (FFM) [by bioelectrical impedance analysis] as an index of muscle mass. Quadriceps and biceps functions were tested by isokinetic methods, and daily activity level was assessed by the Physical Activity Scale for Elderly (PASE) questionnaire. Peak oxygen consumption (O2peak) was measured by incremental cycle ergometry.

Results: PASE results were similar in patients with CHF and in patients with COPD, each group scoring lower than control subjects. FFM was also lower in patients than control subjects and correlated closely with quadriceps and biceps strength in all three subgroups, R values ranging from 0.63 to 0.78, with identical slopes. FFM also correlated significantly with O2peak (p < 0.05), but slopes were less steep in patients than in control subjects. The type and severity of muscle dysfunction were similar in each group of patients. There were no significant correlations between indexes of cardiopulmonary function and muscle function or exercise performance in patients with CHF or in patients with COPD. In both control subjects and patients, FFM was the most significant determinant of O2peak.

Conclusion: Muscle dysfunction is not limited to the lower limbs, but generalized and comparable between patients with CHF and patients with COPD with similar exercise capacity. FFM is a strong predictor of peripheral muscle strength, to a lesser extent of O2peak, and not at all of peripheral muscle endurance.

Key Words: chronic heart failure • COPD • daily activity level • exercise capacity • fat-free mass • isokinetic muscle function




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
A. Agusti
Thomas A. Neff Lecture. Chronic Obstructive Pulmonary Disease: A Systemic Disease
Proceedings of the ATS, August 1, 2006; 3(6): 478 - 481.
[Full Text] [PDF]


Home page
Eur Respir JHome page
F. Pitta, T. Troosters, V. S. Probst, M. A. Spruit, M. Decramer, and R. Gosselink
Quantifying physical activity in daily life with questionnaires and motion sensors in COPD.
Eur. Respir. J., May 1, 2006; 27(5): 1040 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. R. Gosker, P. Schrauwen, R. Broekhuizen, M. K. C. Hesselink, E. Moonen-Kornips, K. A. Ward, F. M. E. Franssen, E. F. M. Wouters, and A. M. W. J. Schols
Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E976 - E981.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. P. Rutten, F. M. Franssen, M. P. Engelen, E. F. Wouters, N. E. Deutz, and A. M. Schols
Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 829 - 834.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers
Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease
Chest, November 1, 2005; 128(5): 3618 - 3624.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Couillard and C. Prefaut
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Eur. Respir. J., October 1, 2005; 26(4): 703 - 719.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Broekhuizen, E F M Wouters, E C Creutzberg, C A P M Weling-Scheepers, and A M W J Schols
Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease
Thorax, May 1, 2005; 60(5): 376 - 382.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.